Header Logo

Sarju Ganatra

Concepts (289)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
24
2025
1348
3.890
Why?
Diabetes Mellitus, Type 2
8
2025
688
3.490
Why?
Cardiovascular Diseases
18
2025
831
3.190
Why?
Myocarditis
14
2024
67
2.540
Why?
Heart Failure
11
2025
899
2.450
Why?
Stroke Volume
9
2024
328
2.140
Why?
Cardiotoxicity
9
2025
15
2.050
Why?
Coronary Artery Disease
4
2025
308
2.000
Why?
Immunotherapy
4
2025
250
1.860
Why?
Water Pollutants, Chemical
2
2025
40
1.860
Why?
Cardiomyopathies
5
2024
123
1.750
Why?
Atrial Fibrillation
6
2024
831
1.520
Why?
Antineoplastic Agents
6
2023
660
1.480
Why?
Stroke
4
2025
1184
1.450
Why?
Percutaneous Coronary Intervention
5
2024
206
1.350
Why?
Hypoglycemic Agents
4
2025
214
1.270
Why?
Humans
86
2025
62541
1.270
Why?
Intracranial Hemorrhages
2
2021
64
1.220
Why?
Climate Change
3
2025
24
1.080
Why?
Ritonavir
3
2023
18
1.080
Why?
Medical Oncology
8
2025
66
1.040
Why?
Immunotherapy, Adoptive
3
2024
96
1.030
Why?
Cardiology
5
2024
167
1.000
Why?
Optic Neuropathy, Ischemic
1
2025
6
0.970
Why?
Seawater
1
2025
11
0.970
Why?
Catheter Ablation
2
2024
153
0.930
Why?
Diabetic Retinopathy
1
2025
53
0.910
Why?
Aged
30
2025
14206
0.880
Why?
Perioperative Care
1
2025
84
0.880
Why?
Environmental Exposure
2
2025
219
0.870
Why?
Heart Diseases
3
2022
215
0.860
Why?
Nervous System Diseases
1
2025
106
0.850
Why?
Middle Aged
27
2025
17298
0.840
Why?
Retrospective Studies
19
2025
6489
0.810
Why?
Cardiovascular Agents
2
2022
103
0.780
Why?
Overweight
1
2024
249
0.770
Why?
Female
36
2025
32398
0.770
Why?
Risk Factors
19
2025
5289
0.760
Why?
Septal Occluder Device
1
2021
11
0.720
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2023
217
0.720
Why?
Cardiac Surgical Procedures
2
2023
262
0.710
Why?
Cross Infection
2
2020
160
0.690
Why?
Atrial Appendage
1
2021
31
0.690
Why?
Male
34
2025
29387
0.690
Why?
Lymphoma, Non-Hodgkin
1
2020
52
0.680
Why?
Cell- and Tissue-Based Therapy
1
2020
39
0.680
Why?
Cardiovascular System
1
2020
40
0.670
Why?
Venous Thrombosis
2
2018
113
0.660
Why?
Drug-Eluting Stents
2
2017
62
0.660
Why?
Obesity
2
2025
1228
0.640
Why?
Hypertension
2
2025
590
0.640
Why?
Heart Function Tests
1
2018
15
0.620
Why?
Medical Overuse
1
2018
11
0.610
Why?
Nontuberculous Mycobacteria
1
2018
8
0.610
Why?
Air Microbiology
1
2018
10
0.610
Why?
Heating
1
2018
9
0.610
Why?
Equipment Contamination
1
2018
33
0.600
Why?
Mycobacterium Infections, Nontuberculous
1
2018
16
0.600
Why?
Immunity, Cellular
1
2019
175
0.600
Why?
Risk Assessment
9
2025
2033
0.590
Why?
Delivery of Health Care
1
2022
428
0.590
Why?
Iliac Vein
1
2018
9
0.580
Why?
Betacoronavirus
1
2020
177
0.580
Why?
Sarcoidosis
1
2018
34
0.580
Why?
Pyrazoles
1
2018
78
0.570
Why?
Pyrimidines
1
2018
135
0.570
Why?
Registries
7
2024
870
0.550
Why?
United States
16
2025
7702
0.550
Why?
Arrhythmogenic Right Ventricular Dysplasia
1
2017
13
0.550
Why?
Vascular Access Devices
1
2017
15
0.540
Why?
Adult
18
2025
16575
0.540
Why?
Coronavirus Infections
1
2020
202
0.540
Why?
Pneumonia, Viral
1
2020
216
0.540
Why?
Stents
2
2017
486
0.520
Why?
Heart Valve Prosthesis Implantation
1
2018
168
0.510
Why?
Tissue Plasminogen Activator
1
2017
126
0.510
Why?
Fibrinolytic Agents
1
2017
169
0.500
Why?
Pharmacovigilance
3
2024
13
0.490
Why?
Thrombolytic Therapy
1
2017
190
0.490
Why?
Treatment Outcome
10
2024
5556
0.480
Why?
Quality of Life
1
2022
1217
0.470
Why?
Pulmonary Embolism
1
2017
169
0.460
Why?
Adverse Drug Reaction Reporting Systems
3
2024
46
0.460
Why?
Ventricular Function, Left
5
2024
268
0.460
Why?
Prevalence
4
2025
1343
0.440
Why?
Aged, 80 and over
12
2025
5389
0.440
Why?
Renal Insufficiency, Chronic
2
2025
128
0.420
Why?
Endovascular Procedures
2
2017
643
0.420
Why?
Cardiologists
2
2023
28
0.410
Why?
Death, Sudden, Cardiac
1
2017
360
0.410
Why?
Air Pollution
2
2023
36
0.410
Why?
Electrocardiography
4
2021
549
0.400
Why?
United States Food and Drug Administration
2
2024
90
0.400
Why?
Kidney Diseases
2
2025
174
0.370
Why?
Pandemics
5
2023
661
0.360
Why?
Angioedema
2
2021
10
0.360
Why?
Myocardial Infarction
3
2023
909
0.330
Why?
Acute Coronary Syndrome
2
2023
253
0.330
Why?
Breast Neoplasms
3
2024
1189
0.310
Why?
Anthracyclines
3
2023
12
0.300
Why?
Heart Rate
2
2021
319
0.290
Why?
Antineoplastic Agents, Immunological
2
2019
46
0.290
Why?
Young Adult
7
2024
4612
0.280
Why?
Hospitalization
6
2024
1338
0.280
Why?
Cardiac Catheterization
2
2021
278
0.270
Why?
Databases, Factual
3
2025
850
0.260
Why?
Observational Studies as Topic
2
2023
57
0.260
Why?
Cross-Sectional Studies
4
2025
2531
0.250
Why?
Randomized Controlled Trials as Topic
3
2024
727
0.240
Why?
Adolescent
7
2024
6150
0.240
Why?
Echocardiography
2
2020
498
0.240
Why?
Social Determinants of Health
2
2024
128
0.240
Why?
Mobility Limitation
1
2025
49
0.230
Why?
Incidence
4
2024
1359
0.230
Why?
Predictive Value of Tests
4
2022
1076
0.230
Why?
Hodgkin Disease
1
2025
56
0.230
Why?
Lymphoma, Large B-Cell, Diffuse
1
2025
68
0.230
Why?
Lymphoma
1
2025
101
0.230
Why?
Drug-Related Side Effects and Adverse Reactions
2
2024
144
0.220
Why?
Stenosis, Pulmonary Vein
1
2024
3
0.220
Why?
Bayes Theorem
1
2024
119
0.220
Why?
Sodium-Glucose Transporter 2
1
2023
6
0.210
Why?
Metabolic Syndrome
1
2025
142
0.210
Why?
Nutrition Surveys
1
2024
142
0.210
Why?
Amyloidosis
1
2024
63
0.210
Why?
Propensity Score
1
2024
154
0.210
Why?
Antibiotics, Antineoplastic
1
2023
36
0.210
Why?
Amyloid Neuropathies, Familial
1
2023
16
0.200
Why?
Anti-Arrhythmia Agents
1
2023
99
0.200
Why?
Drug Interactions
1
2022
127
0.190
Why?
Heart Valve Diseases
1
2023
93
0.190
Why?
Vinca Alkaloids
1
2021
1
0.190
Why?
Transcatheter Aortic Valve Replacement
1
2024
107
0.190
Why?
Taxoids
1
2021
26
0.190
Why?
Air Pollutants
1
2023
93
0.190
Why?
Heart
3
2021
281
0.190
Why?
Follow-Up Studies
2
2024
2441
0.180
Why?
Hyperkalemia
1
2021
20
0.180
Why?
Neoplasm Recurrence, Local
1
2023
334
0.180
Why?
Angiotensin II
1
2021
26
0.180
Why?
Shock
1
2021
33
0.180
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
46
0.180
Why?
Giant Cells
1
2021
15
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2025
444
0.180
Why?
Medicare
2
2023
614
0.180
Why?
Aortic Valve Stenosis
1
2024
186
0.180
Why?
Hypotension
1
2021
50
0.180
Why?
Drug Administration Schedule
2
2020
299
0.180
Why?
Vasoconstrictor Agents
1
2021
70
0.180
Why?
Heart Conduction System
1
2021
53
0.170
Why?
Bundle-Branch Block
1
2020
14
0.170
Why?
Action Potentials
1
2021
103
0.170
Why?
Biopsy
2
2021
429
0.170
Why?
Rural Population
1
2022
202
0.170
Why?
Health Care Costs
1
2022
210
0.170
Why?
Tachycardia, Ventricular
1
2022
129
0.170
Why?
Multimodal Imaging
1
2020
66
0.170
Why?
Platelet Aggregation Inhibitors
2
2023
225
0.170
Why?
Heart Arrest
1
2022
166
0.170
Why?
Atherosclerosis
1
2021
152
0.160
Why?
Practice Patterns, Physicians'
1
2025
707
0.160
Why?
Asthma
1
2023
433
0.160
Why?
Dementia
1
2022
257
0.150
Why?
Adrenal Cortex Hormones
1
2020
173
0.150
Why?
Diagnosis, Differential
2
2018
963
0.150
Why?
Acute Kidney Injury
1
2020
143
0.150
Why?
Physical Examination
1
2018
111
0.150
Why?
Adenine
1
2018
50
0.150
Why?
Piperidines
1
2018
63
0.150
Why?
Lymphoma, B-Cell
1
2018
61
0.150
Why?
Global Health
1
2019
182
0.150
Why?
Operating Rooms
1
2018
55
0.150
Why?
Influenza Vaccines
1
2019
97
0.140
Why?
Comorbidity
2
2019
1117
0.140
Why?
Cardiomyopathy, Hypertrophic
2
2024
763
0.140
Why?
Anticoagulants
2
2022
493
0.140
Why?
Time Factors
3
2024
3737
0.140
Why?
Interdisciplinary Communication
1
2018
104
0.140
Why?
Hypothyroidism
1
2017
42
0.140
Why?
Foreign-Body Migration
1
2017
21
0.140
Why?
Drug Therapy, Combination
1
2018
463
0.140
Why?
Fatal Outcome
1
2017
122
0.130
Why?
Attitude
1
2017
100
0.130
Why?
Pulmonary Disease, Chronic Obstructive
1
2023
689
0.130
Why?
Device Removal
1
2017
65
0.130
Why?
Prosthesis Design
1
2017
223
0.130
Why?
Clinical Trials as Topic
1
2019
452
0.130
Why?
Clinical Decision-Making
1
2017
159
0.130
Why?
Influenza, Human
1
2019
206
0.130
Why?
Computed Tomography Angiography
1
2017
123
0.130
Why?
Ultrasonography, Interventional
1
2017
99
0.130
Why?
Lyme Disease
1
2017
122
0.130
Why?
Equipment Design
1
2017
348
0.120
Why?
Lower Extremity
1
2017
164
0.120
Why?
Patient Selection
1
2017
481
0.120
Why?
Length of Stay
3
2023
796
0.120
Why?
Curriculum
1
2018
585
0.110
Why?
Anti-Bacterial Agents
1
2018
784
0.100
Why?
Magnetic Resonance Imaging
1
2021
2142
0.090
Why?
Valsartan
2
2021
12
0.090
Why?
Aminobutyrates
2
2021
10
0.090
Why?
Trastuzumab
2
2021
14
0.090
Why?
Tetrazoles
2
2021
22
0.090
Why?
Biphenyl Compounds
2
2021
32
0.090
Why?
Drug Combinations
2
2021
152
0.090
Why?
Troponin T
2
2022
24
0.090
Why?
Angiotensin Receptor Antagonists
2
2021
65
0.090
Why?
Inpatients
2
2023
301
0.080
Why?
Hospitals
2
2022
392
0.080
Why?
Algorithms
2
2024
1003
0.070
Why?
Hospital Mortality
2
2022
864
0.070
Why?
Vincristine
1
2025
27
0.060
Why?
Case-Control Studies
2
2018
1107
0.060
Why?
Hematology
1
2025
12
0.060
Why?
Dyslipidemias
1
2025
37
0.060
Why?
Prospective Studies
2
2024
3248
0.060
Why?
Cyclophosphamide
1
2025
79
0.060
Why?
Prednisone
1
2025
86
0.060
Why?
Doxorubicin
1
2025
99
0.060
Why?
Canagliflozin
1
2024
6
0.060
Why?
Pericarditis
1
2024
9
0.060
Why?
Glucosides
1
2024
13
0.060
Why?
Natural Language Processing
1
2024
47
0.050
Why?
Meta-Analysis as Topic
1
2024
78
0.050
Why?
Benzhydryl Compounds
1
2024
51
0.050
Why?
Child
2
2024
4430
0.050
Why?
Cause of Death
1
2024
220
0.050
Why?
Environmental Pollution
1
2023
14
0.050
Why?
Multicenter Studies as Topic
1
2023
137
0.050
Why?
Prealbumin
1
2023
19
0.050
Why?
Prasugrel Hydrochloride
1
2023
12
0.050
Why?
Purinergic P2Y Receptor Antagonists
1
2023
13
0.050
Why?
Adenosine Diphosphate
1
2023
41
0.050
Why?
Mortality
1
2024
160
0.050
Why?
Mitral Valve
1
2023
116
0.050
Why?
Machine Learning
1
2024
174
0.050
Why?
Hemorrhage
1
2024
266
0.050
Why?
Aortic Valve
1
2024
187
0.050
Why?
Societies, Medical
1
2024
362
0.050
Why?
Sex Characteristics
1
2023
203
0.050
Why?
Socioeconomic Factors
1
2024
775
0.050
Why?
Electric Countershock
1
2022
101
0.050
Why?
Arrhythmias, Cardiac
1
2022
149
0.050
Why?
Endocardium
1
2021
13
0.050
Why?
Coronary Artery Bypass
1
2023
297
0.050
Why?
Arterial Pressure
1
2021
27
0.050
Why?
Cardiac Imaging Techniques
1
2021
17
0.040
Why?
Electronic Health Records
1
2024
355
0.040
Why?
Troponin I
1
2021
36
0.040
Why?
Natriuretic Peptide, Brain
1
2021
57
0.040
Why?
Niacinamide
1
2020
33
0.040
Why?
Antiviral Agents
1
2023
321
0.040
Why?
Proteasome Inhibitors
1
2020
30
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2021
143
0.040
Why?
Receptor, ErbB-2
1
2020
55
0.040
Why?
Oxygen
1
2022
316
0.040
Why?
Phenotype
1
2024
1190
0.040
Why?
Radiotherapy
1
2020
64
0.040
Why?
Artificial Intelligence
1
2022
163
0.040
Why?
Gadolinium
1
2020
106
0.040
Why?
Heart Transplantation
1
2021
169
0.040
Why?
Protein Kinase Inhibitors
1
2020
187
0.040
Why?
Magnetic Resonance Imaging, Cine
1
2020
108
0.040
Why?
Renal Dialysis
1
2020
197
0.040
Why?
Magnetic Resonance Spectroscopy
1
2020
293
0.040
Why?
Patient Readmission
1
2023
427
0.040
Why?
Survivorship
1
2018
14
0.040
Why?
Immunosuppressive Agents
1
2021
376
0.040
Why?
Heart-Assist Devices
1
2021
142
0.040
Why?
Dose-Response Relationship, Drug
1
2020
861
0.040
Why?
Methylprednisolone
1
2018
34
0.040
Why?
Interprofessional Relations
1
2019
133
0.040
Why?
Program Development
1
2019
205
0.040
Why?
Defibrillators, Implantable
1
2021
265
0.030
Why?
Contrast Media
1
2020
421
0.030
Why?
T-Lymphocytes
1
2022
1004
0.030
Why?
Cohort Studies
1
2023
2530
0.030
Why?
Exercise Test
1
2018
249
0.030
Why?
Surveys and Questionnaires
1
2025
2641
0.030
Why?
Referral and Consultation
1
2020
421
0.030
Why?
Program Evaluation
1
2019
485
0.030
Why?
Child, Preschool
1
2022
1928
0.030
Why?
Echocardiography, Transesophageal
1
2017
104
0.030
Why?
Glucocorticoids
1
2018
188
0.030
Why?
Vaccination
1
2019
353
0.030
Why?
Melanoma
1
2020
330
0.030
Why?
Biomarkers
1
2021
1379
0.030
Why?
Lung Neoplasms
1
2020
656
0.030
Why?
Tomography, X-Ray Computed
1
2017
1584
0.020
Why?
Ganatra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (289)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_